Links
Useful resources all in one place
STI Screening and Testing
Screening for HIV Infection US Preventive Services Task Force Recommendation Statement
aafp.org/pubs/afp/issues/2005/1201/p2287.pdfWho Should Get Tested? | HIV.gov
hiv.gov/hiv-basics/hiv-testing/learn-about-hiv-testing/who-should-get-testedScreening for HIV | Clinicians | CDC
cdc.gov/hivnexus/hcp/diagnosis-testing/index.html- USPSTF Chlamydia/Gonorrhea Screening Recommendations
uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening - USPSTF Syphilis Screening Recommendations
uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-nonpregnant-adults-adolescents-screening - CDC Laboratory Recommendations for Syphilis Testing
cdc.gov/mmwr/volumes/73/rr/rr7301a1.htm
Prevention
PEP
- Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV—United States, 2016
cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf - Clinical Guidance for PEP
cdc.gov/hivnexus/hcp/pep/?CDC_AAref_Val=https://www.cdc.gov/hiv/clinicians/prevention/prescribe-pep.html - PEPline: Expert consultation for issues and any other guidance on nonoccupational PEP can be obtained by calling the National Clinician Consultation Center’s Post-Exposure Prophylaxis PEPline at 888-448-4911
PrEP
PrEP Effectiveness | CDC
cdc.gov/hiv/basics/prep/prep-effectiveness.htmlEmtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial
pubmed.ncbi.nlm.nih.gov/32711800Antiretroviral prophylaxis for HIV prevention in heterosexual men and women
pubmed.ncbi.nlm.nih.gov/22784037On-Demand PrEP | CDC
cdc.gov/hiv/basics/prep/on-demand-prep.htmlPrEP 2021 CDC Guidelines
cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf
Medical Assistance Programs
Enrollment applications that will be useful in applying for medication assistance programs are:
Gilead’s Advancing Access Form
services.gileadhiv.com/content/pdf/gilead_enrollment_form.pdf, andNASTAD’S Patient Assistance Tool
nastad.org/resources/pharmaceutical-company-patient-assistance-programs-and-cost-sharing-assistance-programsResources for Accessing nPEP
files.hiv.gov/s3fs-public/2023-10/PAP-CAP-Resources-for-Accessing-nPEP.pdf